Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1RECORDATI RARE DISEASES, INC.

02 1Recordati

03 1Recordati Rare Diseases

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Sutimlimabum

Brand Name : Enjaymo

Dosage Form : Infusion Solution

Dosage Strength : 1100mg/22ml

Packaging :

Approval Date : 21/06/2023

Application Number : 68074

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Sutimlimab

Brand Name : Enjaymo

Dosage Form : Infusion Solution

Dosage Strength : 50mg/mL

Packaging :

Approval Date : 15/11/2022

Application Number : 20211011000048

Regulatory Info : Approved

Registration Country : Sweden

blank

03

RECORDATI RARE DISEASES, INC.

Country
AIChE Annual Meeting
Not Confirmed
arrow

RECORDATI RARE DISEASES, INC.

Country
arrow
AIChE Annual Meeting
Not Confirmed

SUTIMLIMAB-JOME

Brand Name : ENJAYMO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1,100MG/22ML(50MG/ML)

Packaging :

Approval Date :

Application Number : 761164

Regulatory Info :

Registration Country : USA

blank